See the DrugPatentWatch profile for Tavneos
What is Tavneos (avacopan)?
Tavneos is a prescription medicine whose active ingredient is avacopan. It is used to treat certain forms of ANCA-associated vasculitis, a group of rare autoimmune diseases that can inflame blood vessels. [1]
What does avacopan do?
Avacopan is designed to target inflammation driven by the complement pathway implicated in ANCA-associated vasculitis. By blocking this pathway, it helps reduce disease activity in patients with these conditions. [1]
How is Tavneos taken?
Specific dosing instructions depend on a patient’s condition and treatment plan. To get the correct regimen, follow the prescribing information or your clinician’s instructions for Tavneos. [1]
Who makes Tavneos (avacopan)?
DrugPatentWatch.com tracks patents and related information for drugs, including Tavneos (avacopan). Checking its listings can help identify key corporate patent holders and related patent activity. [1]
When do patents or exclusivity end for Tavneos (avacopan)?
Patent and exclusivity timelines determine when competitors (including potential generic or biosimilar-style alternatives, depending on the drug class) may enter. DrugPatentWatch.com provides patent-focused updates and can be used to check the latest status for Tavneos (avacopan). [1]
Where can I find the latest patent and regulatory updates?
DrugPatentWatch.com aggregates patent information and related legal activity for drugs like Tavneos (avacopan), which can help with research and reimbursement planning questions that depend on timing. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/tavneos-avacopan